Title

HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults

Publication Date

2009-07-21

UMMS Affiliation

Graduate School of Nursing

Document Type

Article

Disciplines

Health Services Administration | Health Services Research | Substance Abuse and Addiction | Virus Diseases

Abstract

Hepatitis C virus (HCV) infection is a major source of morbidity and mortality among substance users and persons living with human immunodeficiency virus (HIV) infection. Treatment for chronic HCV infection involves complex decision-making. These decisions are even more complicated in persons with HIV and substance use related problems. A secondary analyses of qualitative data collected in the United States (2004-2005) with 31 HIV/HCV coinfected adults (48% women; mean age 44.7 years) revealed three themes related to substance use (substance use evolution, revolving door: going back out and reconstructing life) and two HCV treatment decision-making themes (HCV infection treatment issues: not a priority, fear, misinformation and get clean and try it). Study limitations and implications are discussed.

DOI of Published Version

10.1080/10826080802486897

Source

Subst Use Misuse. 2009;44(7):915-33. doi: 10.1080/10826080802486897. Link to article on publisher's site

Journal/Book/Conference Title

Substance use and misuse

Related Resources

Link to Article in PubMed

PubMed ID

19440928

Link to Full Text

Share

COinS